Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®
Year: 2003
Type: review
Source: Seminars in Cancer Biology
Authors: Vernon K Sondak, Jeffrey A Sosman
Institutions: Michigan Medicine, U-M Rogel Cancer Center, Vanderbilt University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1967551737
